Year in review 2006: Critical care - Multiple organ failure, sepsis, and shock

Critical Care

Volumn 11, Issue , 2007, Pages

  Simkova, Vladislava ^a,b   Baumgart, Katja ^b   Radermacher, Peter ^b   Barth, Eberhard ^b   Calzia, Enrico ^b  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE RECEPTOR; BLOOD CLOTTING FACTOR 13; DOPEXAMINE; DROTRECOGIN; GLUCOCORTICOID; HYDROCORTISONE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MRS 3558; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACEBO; PRASTERONE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACUTE LUNG INJURY; ADRENAL INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; CAPILLARY DENSITY; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOTHELIAL DYSFUNCTION; ENDOTOXEMIA; EXTRAVASATION; HEMORRHAGIC SHOCK; HUMAN; HYPOTHERMIA; INTENSIVE CARE; LEUKOCYTE ADHERENCE; LUNG EDEMA; MICROCIRCULATION; MITOCHONDRIAL RESPIRATION; MULTIPLE ORGAN FAILURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SEPSIS; SHOCK; SURVIVAL RATE; THROMBOCYTE ADHESION; METHODOLOGY;

CRITICAL CARE; HUMANS; MULTIPLE ORGAN FAILURE; SEPSIS; SHOCK;

EID: 34548310383     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5938     Document Type: Review

References (53)

1. Vincent JL De Backer D Microvascular dysfunction as a cause of organ dysfunction in severe sepsis Crit Care 2005 Suppl 4 S9-12 10.1186/cc3748 16168075
2. Sakr Y Dubois MJ De Backer D Creteur J Vincent JL Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock Crit Care Med 2004 32 1825-1831 10.1097/ 01.CCM.0000138558.16257.3F 15343008
3. Hassoun HT Kone BC Mercer DW Moody FG Weisbrodt NW Moore FA Post-injury multiple organ failure: The role of the gut Shock 2001 15 1-10 11198350
4. Birnbaum J Hein OV Lührs C Rückbeil O Spies C Ziemer S Gründling M Usichenko T Meissner K Pavlovic D Effects of coagulation factor XIII on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation in experimental endotoxemia Crit Care 2006 10 R29 1550842 16507148 10.1186/cc3994
5. Birnbaum J Klotz E Spies CD Lorenz B Stuebs P Hein OV Gründling M Pavlovic D Usichenko T Wendt M Effects of dopexamin on the intestinal microvascular blood flow and leucocyte activation in a sepsis model in rats Crit Care 2006 10 R117 1750974 16893450 10.1186/cc5011
6. Payen D Sablotzki A Barie PS Ramsay G Lowry S Williams M Sarwat S Northrup J Toland P McL Booth FV International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: Analyses of efficacy and safety data in a large surgical cohort Surgery 2006 140 726-739 10.1016/j.surg.2006.06.009 17084715
7. Gupta A Berg DT Gerlitz B Sharma GR Syed S Richardson MA Sandusky G Heuer JG Galbreath EJ Grinnel BW Role of protein C in renal dysfunction after polymicrobial sepis J Am Soc Nephrol 2007 18 860-867 10.1681/ ASN.2006101167 17301189
8. Maybauer MO Maybauer DM Fraser JF Traber LD Westphal M Enkhbaatar P Cox RA Huda R Hawkins HK Morita N Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis Crit Care Med 2006 34 2432-2438 10.1097/ 01.CCM.0000230384.61350.FA 16810106
9. Lehmann C Meissner K Knöck A Diedrich S Pavlovic D Gründling M Usichenko T Wendt M Birnbaum J Activated protein C improves intestinal microcirculation in experimental endotoxaemia in the rat Crit Care 2006 10 R157 1794461 17101035 10.1186/cc5093
10. Croner RS Hoerer E Kulu Y Hackert T Gebhard M Herfarth C Klar E Hepatic platelet and leukocyte adherence during endotoxemia Crit Care 2006 10 R15 1550823 16420661 10.1186/cc3968
11. Wichmann MW Zellweger R DeMaso CM Ayala A Chaudry IH Enhanced immune response in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation Cytokine 1996 8 853-863 10.1006/cyto.1996.0114 9047082
12. Choudhry MA Bland KI Chaudry IH Gender and susceptibility to sepsis following trauma Endocr Metab Immune Disord Drug Targets 2006 6 127-135 16787286
13. Oberbeck R Dahlweid M Koch R van Griensven M Emmendorfer A Tscherne H Pape HC Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis Crit Care Med 2001 29 380-384 10.1097/00003246-200102000-00029 11246320
14. Van Griensven M Dahlweid FM Giannoudis PV Wittwer T Bottcher F Breddin M Pape HC Dehydroepiandrosterone (DHEA) modulates the activity and the expression of lymphocyte subpopulations induced by cecal ligation and puncture Shock 2002 18 445-449 10.1097/00024382-200211000-00010 12412624
15. Barkhausen T Westphal B Pütz C Krettek C van Griensven M Dehydroepiandrosterone administration modulates endothelial and neutrophil adhesion molecule expression in vitro Crit Care 2006 10 R109 1750969 16859502 10.1186/cc4986
16. Yang R Tibbs BM Chang B Nguyen C Woodall C Steppacher R Helling T Morrison DC Van Way CW 3rd Effect of DHEA on the hemodynamic response to resuscitation in a porcine model of hemorrhagic shock J Trauma 2006 61 1343-1349 17159675
17. Dvorak HF Brown LF Detmar M Dvorak AM Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am J Pathol 1995 146 1029-1039 1869291 7538264
18. Gerber HP Dixit V Ferrara N Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells J Biol Chem 1998 273 13313-13316 10.1074/ jbc.273.21.13313 9582377
19. Ohwada A Yoshioka Y Iwabuchi K Nagaoka I Dambara T Fukuchi Y VEGF regulates the proliferation of acid-exposed alveolar lining epithelial cells Thorax 2003 58 328-332 10.1136/thorax.58.4.328 12668796
20. Mura M Han B Andrade CF Seth R Hwang D Waddell TK Keshavjee S Liu M The early response of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival Crit Care 2006 10 R130 1751039 16968555 10.1186/cc5042
21. Medford ARL Millar AB Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax 2006 61 621-626 1828639 16807391 10.1136/ thx.2005.040204
22. Rivo J Zeira E Galuan E Matot I Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion Anesthesiology 2004 101 1153-1159 10.1097/00000542-200411000-00015 15505451
23. Schulte G Fredholm BB Signalling from adenosine receptors to mitogen activated protein kinases Cell Signal 2003 15 813-817 10.1016/ S0898-6568(03)00058-5 12834807
24. Xia Z Dickens M Raingeaud J Davis RJ Greenberg ME Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 1995 270 1326-1331 10.1126/science.270.5240.1326 7481820
25. Matot I Weiniger CW Zeira E Galun E Joshi BV Jacobson KA adenosine receptors and mitogen-activated protein A3 kinases in lung injury following in vivo reperfusion Crit Care 2006 10 R65 1550918 16623960 10.1186/cc4893
26. Boulos M Astiz ME Barua RS Osman M Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase Crit Care Med 2003 31 353-358 10.1097/01.CCM.0000050074.82486.B2 12576936
27. Brealey D Brand M Hargreaves I Heales S Land J Smolenski R Davies NA Cooper CE Singer M Association between mitochondrial dysfunction and severity and outcome of septic shock Lancet 2002 360 219-223 10.1016/ S0140-6736(02)09459-X 12133657
28. Crouser ED Julian MW Blaho DV Pfeiffer DR Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity Crit Care Med 2002 30 276-284 10.1097/00003246-200202000-00002 11889292
29. Porta F Takala J Weikert C Bracht H Kolarova A Lauterburg BH Borotto E Jakob SM Effects of prolonged endotoxemia on liver, skeletal muscle and kidney mitochondrial function Crit Care 2006 10 R118 1750984 16895596 10.1186/cc5013
30. Brealey D Karyampudi S Jacques TS Novelli M Stidwill R Taylor V Smolenski RT Singer M Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure Am J Physiol Regul Integr Comp Physiol 2004 286 R491-497 14604843
31. Protti A Singer M Bench-to-bedside review: Potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure Crit Care 2006 10 228 1751057 16953900 10.1186/cc5014
32. Krishnagopalan S Kumar A Parrilo JE Kumar A Myocardial dysfunction in the patient with sepsis Curr Opin Crit Care 2002 8 376-388 10.1097/ 00075198-200210000-00003 12357104
33. Rozenberg S Besse S Brisson H Jozefowicz E Kandoussi A Mebazaa A Riou B Vallet B Tavernier B Endotoxin-induced myocardial dysfunction in senescent rats Crit Care 2006 10 R124 1750995 16942612 10.1186/cc5033
34. Qing M Wöltje M Schumacher K Sokalska M Vazquez-Jimenez JF Minkenberg R Seghaye MC The use of moderate hypothermia during cardiac surgery is associated with repression of tumour necrosis factory-α via inhibition of activating protein-1: An experimental study Crit Care 2006 10 R57 1550898 16606437 10.1186/cc4886
35. Marik PE Zaloga GP Hypothermia and cytokines in septic shock. Norasept II Study Investigators. North American study of the safety and efficacy of murine monoclonal antibody to tumor necrosis factor for the treatment of septic shock Intensive Care Med 2000 26 716-721 10.1007/s001340051237 10945388
36. Scumpia PO Sarcia PJ Kelly KM DeMarco VG Skimming JW Hypothermia induces anti-inflammatory cytokines and inhibits nitric oxide and myeloperoxidase-mediated damage in the hearts of endotoxemic rats Chest 2004 125 1483-1491 10.1378/chest.125.4.1483 15078762
37. Straub A Breuer M Wendel HP Peter K Dietz K Ziemer G Critical temperature ranges of hypothermia-induced platelet activation: Possible implications for cooling patients in cardiac surgery Thromb Haemost 2007 97 608-616 17393024
38. Lindenblatt N Menger MD Klar E Vollmar B Systemic hypothermia incerases PAI-1 expression and accelerates microvascular thrombus formation in endotoxemic mice Crit Care 2006 10 R148 1751084 17062126 10.1186/cc5074
39. Giamarellos-Bourboulis EJ Routsi C Plachouras D Markaki V Raftogiannis M Zervakis D Koussoulas V Orfanos S Kotanidou A Armaganidis A Early apoptosis of blood monocytes in the septic host: Is it a mechanism of protection in the event of septic shock? Crit Care 2006 10 R76 1550931 16696867 10.1186/cc4921
40. Lemineur T Deby-Dupont G Preiser J-Ch Biomarkers of oxidative stress in critically ill patients: What should be measured, when and how? Curr Opin Clin Nutr Metab Care 2006 9 704-710 17053423
41. Halliwell B Whiteman M Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean? Br J Pharmacol 2004 142 231-255 10.1038/sj.bjp.0705776 15155533
42. Chuang C Shiesh S Chi C Tu Y Hor L Shieh C Chen M Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis Crit Care 2006 10 R36 1550865 16507162 10.1186/cc4826
43. Leiper JM Santa Maria J Chubb A MacAllister RJ Charles IG Whitley GS Vallance P Identification of two human dimethylarginin dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginin deiminases Biochem J 1999 343 209-214 1220543 10493931 10.1042/0264-6021:3430209
44. Stuhlinger M Asymmetric dimethyl arginine (ADMA): A novel cardiovascular risk factor? Wien Med Wochenschr 2007 157 57-60 10.1007/ s10354-007-0373-2 17340060
45. Hauser B Bracht H Matejovic M Radermacher P Venkatesh B Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies Anesth Analg 2005 101 488-498 10.1213/01.ANE.0000177117.80058.4D 16037166
46. O'Dwyer MJ Dempsey F Crowley V Kelleher DP McManus R Ryan T Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: A prospective observational study Crit Care 2006 10 R139 1751072 17002794 10.1186/cc5053
47. Prigent H Maxime V Annane D Clinical review: Corticotherapy in sepsis Crit Care 2004 8 122-129 420022 15025773 10.1186/cc2374
48. Salgado DR Verdeal JCR Rocco JR Adrenal function testing in patients with septic shock Crit Care 2006 10 R149 1751047 17062164 10.1186/cc5077
49. Arafah BM Hypothalamic pituitary adrenal function during critical illness: Limitation of current assessment methods J Clin Endocrinol Metab 2006 91 3725-3745 10.1210/jc.2006-0674 16882746
50. Eichacker PQ Natanson C Increasing evidence that the risks of rhAPC may outweigh its benefits Intensive Care Med 2007 33 396-399 10.1007/ s00134-007-0556-8 17325833
51. Abraham E Williams MD Nelson DR Laterre P Bernard GR Vincent JL Baseline characteristics and placebo mortality of severe sepsis patients in the INDEPTH integrated database [abstract] Crit Care Med 2003 31 A123 10.1097/01.CCM.0000053648.42884.89
52. Vincent JL O'Brien J Jr Wheeler A Wittebole X Garg R Trzaskoma BL Sundin DP Use of integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis Crit Care 2006 10 R74 1550949 16684364 10.1186/cc4909
53. Nguyen HB Corbett SW Steele R Banta J Clark RT Hayes SR Edwards J Cho TW Wittlake WA Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality Crit Care Med 2007 35 1105-1112 10.1097/ 01.CCM.0000259463.33848.3D 17334251